Lack of antibodies against the antigen domain 2 epitope of cytomegalovirus (CMV) glycoprotein B is associated with CMV disease after renal transplantation in recipients having the same glycoprotein H serotypes as their donorsKenichi Ishibashi, Tatsuo Suzutani, Naoki Inoue et al.|Transplant Infectious Disease|2010Cited by 24
Cytomegalovirus (CMV) glycoprotein H-based serological analysis in Japanese healthy pregnant women, and in neonates with congenital CMV infection and their mothersKazufumi Ikuta, Tatsuo Suzutani, Toshio Minematsu et al.|Journal of Clinical Virology|2013Cited by 21
A Novel Real-Time PCR Method for Determination and Quantification of Each Cytomegalovirus Glycoprotein H Subtype in Clinical SamplesKazufumi Ikuta, Tatsuo Suzutani, Ken Ishioka et al.|Journal of Clinical Microbiology|2011Cited by 12
Oral valganciclovir treatment for congenital cytomegalovirus infectionTakashi Imamura, Mitsuaki Hosoya, Tatsuo Suzutani et al.|Pediatrics International|2011Cited by 11
Evaluation of the indirect and IgM‐capture anti‐human cytomegalovirus IgM ELISA methods as confirmed by cytomegalovirus IgG avidityKazufumi Ikuta, Tatsuo Suzutani, Tetsuo Koshizuka et al.|Microbiology and Immunology|2019Cited by 11